Tazemetostat hydrobromide
CAS: 1467052-75-0
Ref. 3D-SIC05275
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Informação sobre produto
Tazemetostat hydrobromide is a potent and selective inhibitor of histone methyltransferase. This drug binds to the active site of the enzyme, preventing it from transferring methyl groups. Tazemetostat hydrobromide prevents the activation of cancer-related genes, which has been demonstrated in vitro using various cancer cell lines. Furthermore, this drug acts as an inhibitor of viral replication by inhibiting the production of new viruses. The polymorphic form of tazemetostat hydrobromide is found in human plasma and urine samples and may be used as a biomarker for cancer susceptibility. Tazemetostat hydrobromide may also be used as an antineoplastic agent against certain types of cancers due to its inhibition of histone methylation.
Propriedades químicas
Consulta técnica sobre: 3D-SIC05275 Tazemetostat hydrobromide
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
